BeBetter Med announced that its operating revenue for the third quarter of 2026 was RMB 0.00; the net profit attributable to shareholders of the listed company was a loss of RMB 53.7073 million, and the net profit after deducting non-recurring gains and losses was a loss of RMB 61.8849 million. For the first three quarters of 2026, operating revenue was RMB 0.00; the net profit attributable to shareholders of the listed company was a loss of RMB 151 million, and the net profit after deducting non-recurring gains and losses was a loss of RMB 173 million. The company stated that the increased loss in the third quarter was mainly due to higher R&D expenses.
